IMR Press / EJGO / Volume 39 / Issue 6 / DOI: 10.12892/ejgo4507.2018
Open Access Original Research
Upregulation of ATF3 expression inhibit the proliferation of human uterine serous carcinoma in vitro
G. Yu1J. Liu1X. Sui1T. Wang1W. Wang1G. Qu1, *
Show Less
1 Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, Yantai, China
Eur. J. Gynaecol. Oncol. 2018 , 39(6), 984–987; https://doi.org/10.12892/ejgo4507.2018
Published: 10 December 2018
Abstract

Objects: To investigate the effects of ATF3 upregulation on the proliferation of human uterine serous carcinoma line SPEC-2 and its mechanism. Materials and Methods: Ampho-293 and HEK-293 Fast cells were used to prepare the virus. SPEC-2 cells were infected by polybrene. Western blot experiments were used to verify the success of transfection. The proliferation of cells was detected by MTT method. At different time points, the absorbance of the cells was detected at the wavelength of 490 nm at the enzyme linked immunosorbent assay. The expression of MTP53, ATF3, P21, and CyclinD1 in the cells was detected by Western blot. Results: In negative control and blank control groups, the expression of ATF3 cells was lower in SPEC-2 cells, while the expression of ATF3 protein in the transfection group was significantly higher (p < 0.05 ).The results of MTT showed that the growth rate of SPEC-2 cells was significantly lower than that in the control group. From the experimental results, it can be seen that the expression level of P21 increased, while the expression of MTP53 and CyclinD1 decreased significantly (p < 0.05). Conclusions: High expression of ATF3 in SPEC-2 cells could inhibit the proliferation in vitro. The expression of P21 was activated and the expression of mutant type P53, and CyclinD1 was inhibited which might be the molecular mechanism of inhibition of cell proliferation.
Keywords
Uterine serous carcinoma
ATF3
SPEC-2
Proliferation
Share
Back to top